(Total Views: 447)
Posted On: 10/16/2020 1:14:09 AM
Post# of 155054
By what process did OncoImmune decide this? They had issued a PR saying "halted for efficacy." Lots of good detailed data - wish I had saved it Then the PR disappeared.
I could certainly see the FDA in the background whispering "go for full enrollment" - the analysis was of 203 of a target 270.
At least we saw the data for a short while.
Question for Ohm and others: lessons/changed expectations for CytoDyn?
I could certainly see the FDA in the background whispering "go for full enrollment" - the analysis was of 203 of a target 270.
At least we saw the data for a short while.
Question for Ohm and others: lessons/changed expectations for CytoDyn?
(0)
(0)
